Overview

Pacemaker Holter Assessment of the Effect of BMS-914392 on Atrial Fibrillation Burden

Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether treatment with BMS-914392 is safe, well tolerated and associated with a reduction of atrial fibrillation burden in patients with paroxysmal atrial fibrillation and permanent pacemaker.
Phase:
Phase 2
Details
Lead Sponsor:
Bristol-Myers Squibb